E-Mail Alert

Add your e-mail address to receive forthcoming issues of this journal:

Journal Browser

Journal Browser

Special Issue "Novel Aspects of Lipoprotein Metabolism with Focus on Systemic Inflammation"

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 31 October 2019

Special Issue Editor

Guest Editor
Dr. Robin P.F. Dullaart

Department of Endocrinology, University of Groningen and University Medical Center Groningen, 9700 RB Groningen, The Netherlands
Website | E-Mail
Interests: lipoprotein metabolism; diabetes; metabolic syndrome; inflammatory pathways; NAFLD; thyroid function and CVD risk markers

Special Issue Information

Dear colleagues,

Recently developed high-throughput laboratory techniques regarding lipidomics and metabolomics have enabled one to discern novel cross-talk mechanisms between lipid phenotypes and enhanced chronic inflammation. For example, glycoprotein biomarkers of low-grade inflammation predict incident cardiometabolic diseases and may confer reduced life expectancy, whereas lipoprotein subfractions and lipoprotein compositional features enable one to discern new metabolic phenotypes. This Special Issue of the Journal of Clinical Medicine (IF = 5.583), entitled “Novel Aspects of Lipoprotein Metabolism with a Focus on Systemic Inflammation”, welcomes the submission of manuscripts either describing original research or reviewing the scientific literature. Manuscripts should focus on lipoprotein metabolism and inflammation, particularly in relation to obesity, NAFLD, chronic kidney disease, and pharmacological treatment thereof. Potential topics may include but are not limited to the following:

  • Cellular signalling mechanisms in lipoprotein metabolism;
  • Cross-talk between lipoproteins and inflammation;
  • Importance of low-grade autoimmunity for lipoprotein metabolism;
  • Lipoprotein subfractions and CVD risk assessment;
  • The role of PCSK9-related pathways in insulin secretion and action;
  • Determinants of circulating PCSK9;
  • Hormonal regulation of liver fat.

Dr. Robin P.F. Dullaart
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • cardiometabolic risk markers
  • lipoprotein subfractions
  • lipoprotein autoantibodies
  • low-grade inflammation
  • metabolic syndrome
  • metabolomics
  • PCSK9
  • triglyceride metabolism
  • type 2 diabetes

Published Papers

This special issue is now open for submission, see below for planned papers.

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Role of IL-1 Beta on Statin-Induced Benefits in Patients with Diabetic Cardiomiopathy and Acute Myocardial Infarction
Authors: Federico Carbone, Luca Liberale, Giovanni Camici, Fabrizio Montecucco
University of Genoa, Italy

Non-Linear Relationship between Anti-Apolipoprotein A-1 IgG and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes
Authors: Nicolas Vuilleumier et al.
University of Geneva, Switzerland

Relationship between Macrophage Cholesterol Efflux, Calcium Coronary Artery Content and Antibodies against Apolipoprotein A-1 in Obese and Healthy Subjects
Nicolas Vuilleumier et al.
University of Geneva, Switzerland

Short Term Cooling Increases Plasma ANGPTL3 and ANGPTL8 in Young Healthy Lean Men but Not in Middle-Aged Men with Overweight and Prediabetes
Authors: Laura Janssen, Matti Jauhiainen, Vesa Olkkonen, P.A. Nidhina Haridas, Kimberly Nahon, Patrick Rensen, and Mariëtte Boon
Leiden University, The Netherlands

Cross-Talk between Lipoproteins and Inflammation: The Role of Microvesicles
Authors: Lina Badimon et al.
Autonomous University of Barcelona, Spain

Endothelin Receptor Blocker Improves Proteinuria, PCSK9 and Lipid Profile in Type II Diabetic Patients
Author: J. van den Born
University of Groningen, The Netherlands

J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top